脂肪性肝病恶化后会很复杂，最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。非酒精性脂肪肝会导致肝功能衰竭。
Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis. NAFLD can lead to liver failure.
脂肪性肝病恶化后会很复杂，最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。
Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis.
目的：“消脂化瘀汤”治疗脂肪肝的临床探讨。
Objective: "Disappears the fat soup" to treat the fatty liver the clinical discussion.
清肝活血方并可降低肝纤维化标志物、细胞因子水平，抗肝脏脂质过氧化损伤，较明显改善脂肪肝程度。
QGHXR also showed effects in lowering levels of liver fibrosis markers and cytokines, alleviating the anti-lipid superoxidation damage in liver, and could markedly improve the degree of fatty liver.
目的：观察水林佳(水飞蓟宾磷脂复合物)联合复方丹参滴丸治疗脂肪肝和肝纤维化临床疗效。
OBJECTIVE: To observe the clinical efficacy of silibinin capsules (silibinin phospholipids compound) plus compound Danshen dropping pills for adiposis hepatica and hepatic fibrosis.
近年来，脂肪肝的发病率呈明显上升趋势，且发病年龄趋于低龄化，它已成为严重危害人们健康的常见病、多发病。
The incidence of fat liver is increased in recent years with the age decreased and it has became common disease that damage the health.
目的通过观察疏肝化脂胶囊对大鼠脂肪肝肝脏形态学改变的影响，为临床治疗脂肪肝提供实验依据。
Objective Through observing the effect of SHGHZ capsule based on morphological changes of the fatty liver rats we want to get the experimental case for the clinical therapy of fatty liver.
非乙醇性脂肪性肝病（NAFLD）是一种常见的慢性肝病，其疾病谱包括单纯性脂肪肝、非乙醇性脂肪性肝炎（NASH）、肝纤维化及肝硬化。
Nonalcoholic fatty liver disease(NAFLD) is a kind of chronic liver disease, whose spectrum of the disease includes simple hepar adiposum, steatohepatitis(NASH), hepatic fibrosis, and cirrhosis.
方法分别建立高脂饮食、低脂酒精饮食、高脂酒精饮食和四氯化碳大鼠实验性脂肪肝肝纤维化模型，用免疫组织化学方法观察造模肝组织中弹性蛋白的表达。
Methods Experimental liver fibrosis rats models of were induced by high fat diet, low fat diet plus ethanol, high fat diet plus ethanol, and carbon tetrachloride subcutaneous injection, respectively.
各种有害因素所致的肝损伤可表现为肝坏死、脂肪肝、胆汁郁积、肝纤维化、肝硬化及肝癌等。
The liver injury being caused by various harmful factors were manifested as hepatic necrosis, fatty liver, cholestasis, liver fibrosis, liver cirrhosis and liver cancer and so on.
此文就弹性蛋白酶在高脂血症、脂肪性肝病和肝纤维化治疗中的应用进展作一综述。
This article reviews the advance in the application of elastase to management of hyperlipoidemia, fatty liver disease and hepatic fibrosis.
目的：研究同种异体脂肪干细胞肝内移植对大鼠纤维化肝脏的影响。
AIM: To explore the influence of adipose tissue-derived mesenchymal stem cells (ADMSCs) transplantation on hepatic fibrosis in rats.
目的：研究同种异体脂肪干细胞肝内移植对大鼠纤维化肝脏的影响。
AIM: To explore the influence of adipose tissue-derived mesenchymal stem cells (ADMSCs) transplantation on hepatic fibrosis in rats.
应用推荐